Literature DB >> 15258102

Effects of protein calorie malnutrition on the pharmacokinetics of ketamine in rats.

Marion L Williams1, Donald E Mager, Heli Parenteau, Girish Gudi, Timothy S Tracy, Mike Mulheran, Irving W Wainer.   

Abstract

The effect of protein calorie malnutrition (PCM) on the pharmacokinetics of ketamine (KET) enantiomers has been investigated. Six control and six PCM rats were administered 85 mg/kg racemic KET by intramuscular injection, and plasma concentrations of (S)- and (R)-KET, norketamine (NKET), and 5,6-dehydronorketamine (DNK) were measured using enantioselective gas chromatography. Pharmacokinetic profiles were analyzed using standard noncompartmental and compartmental modeling methods. The volumes of distribution were similar between control and PCM rats for (S)- and (R)-KET. However, total clearance of both KET enantiomers was decreased, resulting in an increase in systemic exposure (p < 0.05). The KET absorption rate was also increased in PCM rats. A decrease in the clearance of both NKET enantiomers led to a significant increase in exposure in PCM rats (p < 0.005), and modeling results could not exclude the possibility that PCM induced an increase in the fraction of KET following the NKET pathway, which may further contribute to this increase in exposure. An increase in exposure to DNK enantiomers was also evident in PCM animals compared with controls [p < 0.005 (DNK1); N.S. (DNK2)], which was in concordance with the decrease in apparent clearance values. These results show that PCM significantly alters the pharmacokinetics of KET and several of its metabolites.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258102     DOI: 10.1124/dmd.32.8.786

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  12 in total

1.  Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior.

Authors:  Rebecca A Brachman; Josephine C McGowan; Jennifer N Perusini; Sean C Lim; Thu Ha Pham; Charlene Faye; Alain M Gardier; Indira Mendez-David; Denis J David; René Hen; Christine A Denny
Journal:  Biol Psychiatry       Date:  2015-05-04       Impact factor: 13.382

2.  Stereoselective and regiospecific hydroxylation of ketamine and norketamine.

Authors:  Zeruesenay Desta; Ruin Moaddel; Evan T Ogburn; Cong Xu; Anuradha Ramamoorthy; Swarajya Lakshmi Vattem Venkata; Mitesh Sanghvi; Michael E Goldberg; Marc C Torjman; Irving W Wainer
Journal:  Xenobiotica       Date:  2012-05-21       Impact factor: 1.908

3.  Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.

Authors:  Xiaochen Zhao; Swarajya Lakshmi Vattem Venkata; Ruin Moaddel; Dave A Luckenbaugh; Nancy E Brutsche; Lobna Ibrahim; Carlos A Zarate; Donald E Mager; Irving W Wainer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

4.  Sex-dependent changes in ketamine-induced locomotor activity and ketamine pharmacokinetics in preweanling, adolescent, and adult rats.

Authors:  Sanders A McDougall; Ginny I Park; Goretti I Ramirez; Vanessa Gomez; Brittnee C Adame; Cynthia A Crawford
Journal:  Eur Neuropsychopharmacol       Date:  2019-04-10       Impact factor: 4.600

5.  Enantioselective pharmacokinetics of (R)- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome.

Authors:  Michael E Goldberg; Marc C Torjman; Robert J Schwartzman; Donald E Mager; Irving W Wainer
Journal:  Chirality       Date:  2010-08-27       Impact factor: 2.437

6.  Neonatal PCP is more potent than ketamine at modifying preweaning behaviors of Sprague-Dawley rats.

Authors:  Sherin Y Boctor; Cheng Wang; Sherry A Ferguson
Journal:  Toxicol Sci       Date:  2008-07-30       Impact factor: 4.849

7.  Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats.

Authors:  Shawn E Kotermanski; Jon W Johnson; Edda Thiels
Journal:  Pharmacol Biochem Behav       Date:  2013-05-08       Impact factor: 3.533

8.  Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan.

Authors:  Naomi Haruta; Hideaki Iizuka; Kana Ishii; Shunsuke Yoshihara; Hideaki Ichiba; Takeshi Fukushima
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

9.  The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats.

Authors:  Ruin Moaddel; Mitesh Sanghvi; Katina Sourou Sylvestre Dossou; Anuradha Ramamoorthy; Carol Green; James Bupp; Robert Swezey; Kathleen O'Loughlin; Irving W Wainer
Journal:  Pharmacol Res Perspect       Date:  2015-06-22

10.  The Resilient Phenotype Induced by Prophylactic Ketamine Exposure During Adolescence Is Mediated by the Ventral Tegmental Area-Nucleus Accumbens Pathway.

Authors:  Eric M Parise; Lyonna F Parise; Omar K Sial; Astrid M Cardona-Acosta; Trevonn M Gyles; Barbara Juarez; Dipesh Chaudhury; Ming-Hu Han; Eric J Nestler; Carlos A Bolaños-Guzmán
Journal:  Biol Psychiatry       Date:  2021-05-08       Impact factor: 12.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.